scholarly journals Phosphoproteomic profiling of mouse primary HSPCs reveals new regulators of HSPC mobilization

Blood ◽  
2016 ◽  
Vol 128 (11) ◽  
pp. 1465-1474 ◽  
Author(s):  
Leo D. Wang ◽  
Scott B. Ficarro ◽  
John N. Hutchinson ◽  
Roland Csepanyi-Komi ◽  
Phi T. Nguyen ◽  
...  

Key Points Combining flow cytometry and high-performance mass spectrometry enables phosphoproteomic analysis of rare blood cell populations. ARHGAP25 dephosphorylation augments activity and promotes blood stem and progenitor cell mobilization by enhancing CXCL12 and Rac signaling.

2019 ◽  
Vol 95 (7) ◽  
pp. 737-745 ◽  
Author(s):  
Sinmanus Vimonpatranon ◽  
Kesinee Chotivanich ◽  
Kasama Sukapirom ◽  
Sakaorat Lertjuthaporn ◽  
Ladawan Khowawisetsut ◽  
...  

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 4711-4711
Author(s):  
Kent W. Christopherson ◽  
Laura A. Paganessi ◽  
Darilyn R. Rhoades ◽  
Hortense M. Dillon ◽  
Sefer Gezer ◽  
...  

Abstract Chronic Lymphocytic Leukemia (CLL) is a lymphoproliferative disorder manifested by a clonal expansion of mature long-lived functionally defective lymphocytes that are predominantly of B-cell origin (>95% of cases). CLL cells typically express the pan-B-cell antigens CD19 and CD20 as wells as CD5, an antigen of mature T-cells, which is present in 95% of B-CLL patients and is helpful for diagnosis. The disease has a median survival of 8–10 years. Asymptomatic patients (RAI stages 0–2) are often not treated. RAI stages 3 & 4 are generally treated. Current therapies for CLL included a combination of monoclonal antibodies (anti-CD20 monoclonal antibody, rituximab) with purine analogs (fludarabine or pentostatin) and alkylating agents (cyclophosphamide). Current therapies to manage B-cell CLL are not curative and therefore suggest that the current strategy of targeting therapy against B-cells may leave behind residual disease that contributes to progression or relapse. The importance of more primitive Hematopoietic Stem and Progenitor cell populations in B-CLL patients has not been considered. We hypothesized that circulating cells may be spontaneously mobilized into the periphery of CLL patients and would therefore contribute to the peripheral blood microenvironment. To test this hypothesis we examined existing CLL cell populations from un-treated “watch-and-wait” B-CLL patients as compared to normal volunteer donor peripheral blood cell populations utilizing multivariate flow cytometric analysis. We determined CD34+CD38−, CD34+CD38+, and CD10 levels in normal peripheral blood to be 81.0±14.5, 497.3±78.33, and 83.6±17.5 cells/ml respectively. We report here the presence of abnormally high levels of these stem and progenitor cell populations in B-CLL patients (see table). Although the mechanism behind the release of these cells into the periphery in B-CLL patients is unknown, it is reasonable to propose that they may be contributing to the manifestation of the disease and are therefore potential novel target cell populations for future therapies. B-CLL Patients WBC β2m CD34+CD38− CD34+CD38+ CD10+ White Blood Cell (WBC) counts are expressed as 1x106 cells/ml. All other counts are expressed as cells/ml 7.93 2.4 2,526 14.6 23,119 11.86 U 3,145 58.2 1,449 12.5 U 307 11.72 1,773 16.9 3.7 6,450 251 3,771 17.24 3.0 28 5.79 8,024 19.37 1.8 4,086 180 8,247 19.9 U 1,790 18.6 3,099 19.92 U 529 34.1 16,039 25.81 1.8 2,937 194 4,617 31.21 2.9 20,753 304 24,340 43.13 1.5 1,577 260.49 281,976 73.98 3.2 1,099 1,767 77,525 105.53 2.2 3,266 220 24,070


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 4727-4727
Author(s):  
Guat Bee Tan ◽  
Christina Sum ◽  
Ponnudurai Kuperan

Abstract Abstract 4727 The examination of blood films by microscopy remains one of the major labour intensive procedures in the laboratory and the challenge is to reduce the number of blood films examined without missing important diagnostic information. Automated blood cell counters offer a leucocyte count, red cell and platelet count and five-part (some 6-part) leucocyte differential. Haematology instrument differentials provide only limited information on cell morphology using abnormal cell flags and are often unable to reliably classify abnormal and immature cells. The examination of blood films is not only time consuming, it also requires highly trained staff. The impact of a wrong diagnosis necessitates that experienced staff are present in the laboratory 24 hours a day. Furthermore, manual cell classification is subjective, with significant inter and intra observer variation (Koepke et al. 1985) and is also subject to significant statistical variance (Rumke 1985). There have recently been several reports of using monoclonal antibody cocktails for an extended leucocyte differential by flow cytometry (Faucher et al. 2007, Roussel et al. 2010). The aim of this study was to compare a flow cytometric method for the white blood cell differential with the automated count from the Beckman Coulter LH750 haematology analyser and the reference manual microscopic 2 × 200 cell count (CLSI H20-A2). Cell morphology was also assessed microscopically for the presence of cells such as reactive or abnormal lymphocytes or blasts. The flow cytometric method, described by Faucher et al. 2007, uses 6 antibodies (CD45, CD36, CD2, CD294, CD19 and CD16) premixed in a single tube. The protocol allows detection of all white blood cells, mature neutrophils, total lymphocytes, total monocytes, eosinophils, basophils, immature granulocytes, B lymphocytes, non-cytotoxic T-lymphocytes, cytotoxic T/NK lymphocytes, CD16 positive and CD16 negative monocytes, and blasts cells with lineage orientation. A 5-colour flow cytometer, the Beckman Coulter FC500, was used for analysis. The gating strategy described by Faucher et al. (2007) was used. EDTA blood was analysed on 27 normal samples and 148 abnormal samples which demonstrated abnormal cell flags on the LH750. These samples included the presence of blast cells, immature granulocytes and abnormal lymphocytes. Results for most cell populations measured by the flow cytometric differential compared well with both the LH750 automated differential and the manual reference method. Comparative results using Pearson correlation show that the automated LH750 differential produced r values of greater than 0.94 for neutrophils, lymphocytes and eosinophils. The manual reference method produced r values of greater than 0.89 for neutrophils, lymphocytes and eosinophils. Results for flow cytometric monocytes compared to the LH750 and manual differential gave an r value of 0.84 and 0.87 respectively. Results for basophils were significantly better when the flow cytometric method was compared to the LH750 rather than the manual method, r = 0.68 for flow cytometry versus LH750 and r = 0.43 for flow cytometry versus manual method. The value of the manual differential is diminished because of the low number of cells counted; the precision is not good for smaller cell populations (Hübl et al. 1995). Very good correlation of blast cells, r = 0.98 and immature granulocytes, r = 0.92 was seen between the manual and flow cytometric method. The flow cytometric differential is superior to the microscopic method since it is objective and due to the higher number of cells counted, it can detect subpopulations of cells that are present in smaller number with greater statistical and interpretive confidence. More importantly, it recognises and quantitates morphologically abnormal cells such as reactive lymphocytes, inflammatory monocytes and the lineage of blast cells. However, the examination of blood cell morphology by microscopy still has an important role in the diagnosis of diseases. Disclosures: No relevant conflicts of interest to declare.


2008 ◽  
Vol 89 (4) ◽  
pp. 741-747 ◽  
Author(s):  
D. Blanchard ◽  
V. Bruneau ◽  
F. Germond-Arnoult ◽  
D. Bernard ◽  
A. Gourbil ◽  
...  

Blood ◽  
2006 ◽  
Vol 108 (11) ◽  
pp. 4193-4193
Author(s):  
Jean-Emmanuel Sarry ◽  
Gwenn-ael Danet-Desnoyers ◽  
Martin Carroll ◽  
Stephen G. Emerson ◽  
Fevzi Daldal ◽  
...  

Abstract Mitochondria play a special role in iron metabolism as the site of heme synthesis for hemoglobin. Mitochondria also function in cellular respiration, apoptosis, amino acid synthesis, Fe-S cluster formation and repair, and redox homeostasis; different blood cell lineages depend on some or all of these diverse mitochondrial functions. Mitochondrial abnormalities in hematopoietic stem cells might manifest themselves in proteomes of all the hematopoietic lineages. Therefore, we have begun characterization of mitochondria from different peripheral blood cell populations: platelets, lymphocytes, neutrophils and reticulocytes with the objective of comparing their function and proteomes in normals and in certain disease states. The procedures utilized as starting material a blood draw of approximately 80 ml from normal volunteers. The peripheral blood samples were separated by centrifugation and Hypaque density gradient into platelet, mononuclear cell, neutrophil and red cell populations. The red cells were further sorted by density gradient and magnetic cell sorting with specific CD71 microbeads to obtain enrichment of reticulocytes (reticulocytes retain their mitochondria and lose these upon maturation into mature red cells). The various cell fractions were evaluated by cell counting, flow cytometry and staining for morphology and identification. In accordance with differences in size and surface characteristics of these cell types, different procedures for cell rupture were utilized: shearing with a home-made device using ball bearings (mononuclear cells, neutrophils), nitrogen cavitation (platelets) and hypotonic shock (reticulocytes). Mitochondria were prepared by differential centrifugation and Percoll density gradient separation. The mitochondria were evaluated by fluorescence microscopy, flow cytometry, marker enzyme activity (succinate dehydrogenase) and Western blotting with compartment-specific antibodies. Mitochondrial protein profiles were obtained using 2-dimensional gel electrophoresis coupled to mass spectrometry. From 80 ml blood, 50 million lymphoctes were obtained equivalent to 150 microgram mitochondrial protein and 10 fold enrichment of succinate dehydrogenase activity. In parallel, K562 cell mitochondria were studied. The imaging analysis revealed significant differences in the protein patterns due to hematopoietic cell lineage. This work seeks to establish a proteomic database of shared and distinct erythroid, myeloid and lymphoid mitochondrial proteins that will form the basis of future studies of blood diseases in which perturbations of mitochondrial proteins are expected to occur. We are especially interested in examining the mitochondrial proteome and correlating with mitochondrial function in myelodysplasia and sideroblastic anemia.


Cancers ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 2291
Author(s):  
Klaus Geissler ◽  
Bettina Gisslinger ◽  
Eva Jäger ◽  
Roland Jäger ◽  
Ana-Iris Schiefer ◽  
...  

Normal hematopoietic function is maintained by a well-controlled balance of myelomonocytic, megaerythroid and lymphoid progenitor cell populations which may be skewed during pathologic conditions. Using semisolid in vitro cultures supporting the growth of myelomonocytic (CFU-GM) and erythroid (BFU-E) colonies, we investigated skewed differentiation towards the myelomonocytic over erythroid commitment in 81 patients with myelofibrosis (MF). MF patients had significantly increased numbers of circulating CFU-GM and BFU-E. Myelomonocytic skewing as indicated by a CFU-GM/BFU-E ratio ≥ 1 was found in 26/81 (32%) MF patients as compared to 1/98 (1%) in normal individuals. Patients with myelomonocytic skewing as compared to patients without skewing had higher white blood cell and blast cell counts, more frequent leukoerythroblastic features, but lower hemoglobin levels and platelet counts. The presence of myelomonocytic skewing was associated with a higher frequency of additional mutations, particularly in genes of the epigenetic and/or splicing machinery, and a significantly shorter survival (46 vs. 138 mo, p < 0.001). The results of this study show that the in vitro detection of myelomonocytic skewing can discriminate subgroups of patients with MF with a different phenotype, a different mutational profile and a different prognosis. Our findings may be important for the understanding and management of MF.


Cytometry ◽  
1996 ◽  
Vol 25 (3) ◽  
pp. 287-294 ◽  
Author(s):  
Kovit Pattanapanyasat ◽  
Kosol Yongvanitchit ◽  
D. Gray Heppner ◽  
Pongsri Tongtawe ◽  
Dennis E. Kyle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document